
AstraZeneca lifts revenue guidance on COVID treatment
By Natalie Grover and Ludwig Burger (Reuters) -AstraZeneca said it expected prescriptions of its COV...
29th July, 2022

By Natalie Grover and Ludwig Burger (Reuters) -AstraZeneca said it expected prescriptions of its COV...
29th July, 2022

By Ludwig Burger and Riham Alkousaa (Reuters) -Shares in the world’s largest kidney dialysis provide...
28th July, 2022

By Emma Farge GENEVA (Reuters) – Less than a month after a hard-won deal was reached on a partial wa...
7th July, 2022

By Natalie Grover LONDON (Reuters) – Diagnostic companies are racing to develop tests for monkeypox,...
3rd June, 2022

By Emma Farge, Jennifer Rigby and Mrinalika Roy GENEVA (Reuters) -The World Health Organization asse...
26th May, 2022

By Hyonhee Shin SEOUL (Reuters) -North Korea is ramping up production of drugs and medical supplies...
19th May, 2022

By Josh Smith and Joori Roh SEOUL (Reuters) -Leader Kim Jong Un has ordered North Korea’s military t...
16th May, 2022

By Michael Erman and Manas Mishra (Reuters) – COVID-19 vaccine makers are shifting gears and plannin...
9th May, 2022

(Reuters) – The European Union’s drug regulator said on Thursday it hoped to have vaccines adapted t...
5th May, 2022

By Elizabeth Piper, Kylie MacLellan and William James LONDON (Reuters) -British Prime Minister Boris...
8th September, 2021

By Andrew MacAskill LONDON (Reuters) – Britain will set aside a further 5.4 billion pounds ($7...
7th September, 2021

SYDNEY (Reuters) – Nearly half a million doses of the Pfizer-BioNTech COVID-19 vaccine arrived...
6th September, 2021